Rigel Pharmaceuticals Inc. (RI2)
Market Open
16 Apr, 07:04
XFRA 
€
14. 80
-0.5
-3.27%
€
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.06 Eps
€ 15.3
Previous Close Day Range
14.8 14.8
Year Range
7.71 26.8
Earnings results expected in 19 days
Want to track RI2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RIGL Rigel Pharmaceuticals Inc 5 May 2025 (19 Days) | | - Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 4 Mar 2025 | | 0.58 Cons. EPS | 0.8 EPS |
| RIGL Rigel Pharmaceuticals Inc 3 Mar 2025 | | - Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 7 Nov 2024 | | 0.06 Cons. EPS | 0.7 EPS |
| RIGL Rigel Pharmaceuticals Inc 5 Nov 2024 | | 0.06 Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 6 Aug 2024 | | - Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 30 Jul 2024 | | - Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 7 May 2024 | | - Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 30 Apr 2024 | | - Cons. EPS | - EPS |
| RIGL Rigel Pharmaceuticals Inc 5 Mar 2024 | | - Cons. EPS | 0 EPS |
2025 © Marketlog. All Rights Reserved.
